LLY

Lilly(Eli) & Co

1,152.93

Sep 18 • 3:59 PM ET +0.49 (0.04%)

1,154.00

Aftermarket • 7:59 PM ET +1.07 (0.09%)

Healthcare Drug Manufacturers - General USA Mega NYSE

Sep 18, 2:00 PMU.S. FDA grants full approval to Eli Lilly's Inluriyo plus Verzenio for ER+, HER2-, ESR1-mutated advanced breast cancer

Peers: NVO PFE MRK ABBV JNJ BMY AZN NVS AMGN SNY

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT SPYM

Scroll to Statements

Index	S&P 500
Market Cap	1085.32B
Enterprise Value	1131.28B
Income	26.71B
Sales	79.67B
Book/sh	35.98
Cash/sh	9.51
Dividend Est.	6.88 (0.60%)
Dividend TTM	6.69 (0.58%)
Dividend Ex-Date	Aug 14, 2026
Dividend Gr. 3/5Y	15.24% 15.18%
Payout	26.14%
Employees	50000
IPO	Jul 09, 1970

P/E	39.18
Forward P/E	24.67
PEG	0.81
P/S	13.62
P/B	32.04
P/C	121.26
P/FCF	59.67
EV/EBITDA	27.13
EV/Sales	14.20
Quick Ratio	1.00
Current Ratio	1.35
Debt/Eq	1.62
LT Debt/Eq	1.41
Option/Short	Yes / Yes

EPS (ttm)	29.43
EPS next Y	46.73
EPS next Q	9.85
EPS this Y	50.41%
EPS next Y	28.33%
EPS next 5Y	30.38%
EPS past 3/5Y	49.25% 27.59%
Sales past 3/5Y	31.69% 21.58%
EPS Y/Y TTM	95.08%
Sales Y/Y TTM	49.58%
EPS Q/Q	26.20%
Sales Q/Q	47.67%
Earnings	Aug 05 BMO
EPS/Sales Surpr.	30.92% 10.33%

Insider Own	9.87%
Insider Trans	-0.03%
Inst Own	76.29%
Inst Trans	0.00%
ROA	21.96%
ROE	102.43%
ROIC	32.68%
Gross Margin	83.40%
Oper. Margin	49.72%
Profit Margin	33.53%
SMA20	-0.89%
SMA50	-2.07%
SMA200	8.12%
Trades

Shs Outstand	941.50M
Shs Float	848.42M
Short Float	0.93%
Short Ratio	2.92
Short Interest	7.89M
52W High	1292.65 -10.81%
52W Low	712.05 61.92%
Volatility	1.94% 2.28%
ATR (14)	29.51
RSI (14)	47.24
Beta	0.45
Rel Volume	1.68
Avg Volume	2.70M
Volume	4,550,033

Perf Week	3.34%
Perf Month	-9.95%
Perf Quarter	4.95%
Perf Half Y	25.66%
Perf YTD	7.28%
Perf Year	51.12%
Perf 3Y	101.82%
Perf 5Y	401.06%
Perf 10Y	1363.11%
Recom	1.50
Target Price	1359.46
Prev Close	1152.44
Price	1152.93
Change %	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-15-26	Upgrade	Berenberg	Hold → Buy	$1400
Mar-17-26	Downgrade	HSBC Securities	Hold → Reduce	$850
Feb-25-26	Initiated	RBC Capital Mkts	Outperform	$1250
Feb-20-26	Initiated	Barclays	Overweight	$1350
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997

Show Previous Ratings

Sep-19-26 05:12PM	Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices (Bloomberg)
Sep-18-26 09:36PM	How to position for the next wave of AI-led scientific breakthroughs (Investing.com)
05:23PM	What Would It Take For Eli Lilly Stock To Keep Climbing? (Trefis)
04:14PM	Is Johnson & Johnson Stock Expensive, Or Is STELARA Hiding The Real Price? (Trefis)
02:09PM	Merck Stock Nearly Doubled Without A Change In Its Revenue Growth (Trefis)
01:54PM	Loading…
01:54PM	U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer (PR Newswire)
08:30AM	Lillys Newest Bull Says Near 300% Rally Is Only the Beginning (Bloomberg)
08:11AM	Entera Receives $9 Price Target and New 'Outperform' Rating From Leerink Partners (NASDAQ: ENTX) (FinanceWire)
Sep-17-26 05:44PM	TWST Stock Hits Multi-Year High, But Pharma Bro Martin Shkreli Calls Twist A Short (Stocktwits)
03:17PM	Can Volume Keep Covering Eli Lilly's Price Cuts? (Trefis)
08:11AM	What Happens To AbbVie Stock If SKYRIZI Slows Down? (Trefis)
Sep-16-26 04:12PM	Is Pfizer's New Business Big Enough To Carry The Old One? (Trefis)
03:12PM	Should You Judge JNJ Stock Without STELARA? (Trefis)
12:33PM	Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal Is Betting on It. (Barrons.com)
09:05AM	Novo Nordisk Taps Anthropics Claude Science To Speed Up Drug Discovery Heres Everything Investors Need To Know (Stocktwits)
07:59AM	Loading…
07:59AM	Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs (Reuters)
06:44AM	NVO To Present Fresh Data From Blockbuster Wegovy Pill At European Conference As Rival Eli Lilly Readies Its Own Obesity Updates (Stocktwits)
05:41AM	Eli Lilly and QurCan sign genetic medicine deal (Pharmaceutical Business Review)
Sep-15-26 08:44PM	Merck Stock: Is The $70 Billion Pipeline Worth the Premium? (Trefis)
04:22PM	Analyst Tweaks Eli Lilly Stock After Weight-Loss Surge (GuruFocus.com)
11:47AM	Novo Nordisk Stock Falls After Major Rebrand (GuruFocus.com)
11:20AM	Berenberg Lifts Lilly to Buy With a $1,400 Target (GuruFocus.com)
11:18AM	Slate Medicines Names Kenneth Koblan as Chief Scientific Officer (Exec Edge)
10:19AM	Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy (Barrons.com)
09:52AM	Eli Lilly To Present Fresh Data On Foundayo, Retatrutide In Europe Heres Why Berenberg Sees A 21% Potential Upside In LLY Stock (Stocktwits)
09:35AM	Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls (The Fly)
09:32AM	Eli Lilly Shares Rise 1.6% as Berenberg Upgrades Stock to Buy (InvestorsHub)
09:32AM	Berenberg bullish on Eli Lilly, sees nearly 25% upside (Investing.com)
08:15AM	Eli Lilly and Novo Nordisk have paid more than 270,000 doctors one as much as $1M to promote GLP-1 weight-loss drugs (Moneywise)
06:45AM	Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health (PR Newswire)
12:08AM	Loading…
12:08AM	AI Safety Fears Drive Investors to J&J, Costco, and CrowdStrike for Cybersecurity (BeInCrypto)
Sep-14-26 10:05PM	Novo Nordisk Rebrands as Novo': Stock Falls as Company Aims GLP-1s at Consumers (BeInCrypto)
04:09PM	Is This LLY Stock Dip Big Enough To Be Worth Buying? (Trefis)
03:57PM	Why Is Pfizer Stock Paying You So Much To Wait? (Trefis)
02:47PM	Novo Nordisk Is Dropping Some Weight. It Still Faces a Bigger Challenge. (Barrons.com)
09:20AM	Novo drops 'Nordisk' in corporate refresh to take on Lilly in the weight-loss wars (MarketWatch)
08:49AM	Novo Nordisk rebrands as Novo to compete in obesity market (Quartz)
04:51AM	NVO Stock Logs Worst Week Since February As Novo Nordisk Rebrands To Novo Amid Another Gloomy Year (Stocktwits)
04:41AM	Novo ditches Nordisk from name as drugmaker attempts revival (Financial Times)
03:59AM	Big Pharma Is Pouring Billions Into China's Biotechs (Barrons.com)
Sep-11-26 05:10PM	Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly Competition (GuruFocus.com)
03:11PM	Is AbbVie Stock Actually Overpriced? (Trefis)
11:34AM	Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent Cliff (GuruFocus.com)
09:02AM	Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions (PR Newswire)
01:00AM	Growth Without AI: 8 Stock Picks (Barrons.com)
Sep-10-26 03:10PM	Merck Stock Vs. LLY: Why Is The Slower Grower More Expensive? (Trefis)
01:57PM	JNJ Stock: Is the Rally Running Out of Steam? (Trefis)
11:05AM	Why Has AbbVie Gone Quiet About Humira? (Trefis)
Sep-09-26 04:43PM	Top Analyst Reports for Eli Lilly, Palo Alto Networks & Texas Instruments (Zacks)
04:41PM	What Eli Lilly Was Telling You While It Rationed Its Own Launches (Trefis)
07:54AM	Kura spins diabetes work into a Lilly-backed biotech startup (BioPharma Dive)
Sep-08-26 02:13PM	Why the CNS boom owes its success to breakthroughs in neurological pathologies (Pharmaceutical Technology)
01:35PM	GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could Be Another Huge Market. (Barrons.com)
01:08PM	Is AbbVie Stock Too Reliant On Skyrizi? (Trefis)
10:36AM	What Merck Stopped Saying About GARDASIL Should Change What You Watch (Trefis)
09:53AM	Novartis's failed trial for cholesterol drug leads to broad biopharma selloff (MarketWatch)
08:56AM	Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, Lilly (Quartz)
Sep-06-26 05:49PM	Eli Lillys $100B incretin opportunity: Is more upside coming? (Investing.com)
Sep-05-26 08:30AM	Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. (MarketWatch)
Sep-04-26 12:57PM	Was JNJ Stock Rally Actually Its Own? (Trefis)
07:56AM	This week in charts: China deals, stock flatlines and Lillys M&A spree (BioPharma Dive)
06:39AM	Superluminal Medicines secures $60m to advance rare obesity therapy (Pharmaceutical Business Review)
Sep-03-26 05:35PM	Lilly's African Mounjaro Push Starts at 1.25% of Quarterly Sales (GuruFocus.com)
01:39PM	Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense (Barrons.com)
12:07PM	Is Merck Stock Pricing In A Post-Keytruda Future Too Soon? (Trefis)
11:54AM	ABBV Stock Has Returned $62 Billion To Shareholders. Should You Care? (Trefis)
11:24AM	Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided? (Trefis)
Sep-02-26 02:19PM	Can AI Save Pfizer Stock Before Its Patent Cliff Hits? (Trefis)
01:16PM	How Did Merck Stock Beat The Market With Slowing Sales? (Trefis)
08:05AM	Peptide innovator says the drug class is due for a rethink (Pharmaceutical Technology)
Sep-01-26 01:28PM	Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in Germany (GuruFocus.com)
10:00AM	Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference (PR Newswire)
07:15AM	Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal (Pharmaceutical Technology)
02:09AM	SLS, IBRX Stocks Post August Gains: Eli Lillys Latest $2.9B Deal Has Retail Traders Bracing For An M&A Rampage (Stocktwits)
Aug-31-26 10:49PM	Lilly's $2.88 Billion Immunology Deal Starts in Phase 1 (GuruFocus.com)
06:08PM	Chris Benecchi Named Inventivas New Chief Operating Officer (Exec Edge)
01:55PM	Eli Lilly CEO Says $25B Deal Spree Is About Building Growth Beyond Obesity Into 2030s Not All These Bets Will Pay Off (Stocktwits)
12:31PM	Eli Lilly Stock Falls After Pharma Giant Unveils $2.9 Billion Acquisition (GuruFocus.com)
11:32AM	Eli Lilly's Next $2.9 Billion Bet Is Not About Obesity (GuruFocus.com)
11:08AM	Eli Lilly to buy Merida Biosciences for up to $2.88B, expanding immunology pipeline (Proactive)
08:55AM	Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market (NASDAQ: ENTX) (FinanceWire)
08:37AM	Eli Lilly Strikes $2.9B Deal For Its 13th Acquisition This Year As Fresh Zepbound Data Impresses (Stocktwits)
07:51AM	Eli Lilly is buying a biotech startup for nearly $3 billion to expand into autoimmune diseases (Quartz)
07:49AM	Eli Lilly buying Merida Biosciences for up to $2.875 billion (Quartz)
07:23AM	Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. (Barrons.com)
07:00AM	New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity (PR Newswire)
06:45AM	Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases (PR Newswire)
05:09AM	Social anxiety drugs have been floundering in the clinic. Could Eli Lilly help tip the scales? (Pharma Voice)
Aug-28-26 03:09PM	Did A Product Swap Fuel JNJ Stocks 54% Surge? (Trefis)
02:35PM	Can Merck Stock Outrun Its Pipeline? (Trefis)
01:50PM	Novo's Wegovy Pill Enters China Behind Lilly (GuruFocus.com)
01:40PM	Eli Lilly's diabetes drug Mounjaro gets approval for a new use (USA TODAY)
01:19PM	Eli Lilly Stock Gets a Fresh Catalyst as FDA Clears Mounjaro for Heart Risk (GuruFocus.com)
01:10PM	Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk (Quartz)
01:05PM	Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label (GuruFocus.com)
10:14AM	Eli Lilly Scores Major FDA Win for Weight Loss Drug (GuruFocus.com)
10:12AM	Mounjaro Just Opened a Much Bigger Door (GuruFocus.com)
08:24AM	Mounjaro Vs Trulicity: Eli Lillys New FDA Win Puts Its Blockbuster Weight-Loss Drug In Focus (Stocktwits)
07:00AM	FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes (PR Newswire)
Aug-27-26 08:19PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

ChairmanMr. David A. Ricks

Executive VP & CFOMr. Lucas E. Montarce

Ph.D.Dr. Daniel M. Skovronsky M.D.

Executive VPMs. Anat Hakim J.D.

Executive VPMr. Jacob S. Van Naarden

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jonsson Patrik	EVP & President, LLY Int'l	Aug 17 '26	Sale	1175.10	6,500	7,638,150	54,147	Aug 18 04:20 PM
Patrik Jonsson	Officer	Aug 17 '26	Proposed Sale	1175.10	6,500	7,638,150		Aug 17 05:06 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 10 '26	Sale	1185.01	2,000	2,370,020	1,526	Aug 11 04:31 PM
DONALD ZAKROWSKI	Officer	Aug 10 '26	Proposed Sale	1185.71	2,000	2,371,420		Aug 10 04:31 PM
Hakim Anat	EVP, GC & Secretary	Aug 07 '26	Sale	1190.00	5,000	5,950,000	11,875	Aug 10 04:19 PM
Hakim Anat	Officer	Aug 07 '26	Proposed Sale	1190.00	10,000	11,900,000		Aug 07 10:30 AM
Seymour Melissa	EVP, Global Quality	Aug 01 '26	Option Exercise	0.00	981	0	1,506	Aug 03 04:42 PM
LILLY ENDOWMENT, INC.	Shareholder	Jul 07 '26	Proposed Sale	1200.06	310,000	372,018,600		Jul 07 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	Jun 26 '26	Proposed Sale	1127.69	305,000	343,945,450		Jun 26 01:40 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Jun 10 '26	Sale	1150.77	2,500	2,876,925	29,804	Jun 11 04:23 PM
Yuffa Ilya	Officer	Jun 10 '26	Proposed Sale	1150.77	2,500	2,876,925		Jun 10 11:03 AM
LILLY ENDOWMENT, INC.	Shareholder	May 28 '26	Proposed Sale	1082.92	310,000	335,705,200		May 28 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	May 22 '26	Proposed Sale	1041.65	300,000	312,495,000		May 22 02:05 PM
LILLY ENDOWMENT, INC.	Shareholder	May 20 '26	Proposed Sale	1021.41	305,000	311,530,050		May 20 04:22 PM
LILLY ENDOWMENT INC	Former 10% Shareholder	May 06 '26	Sale	995.36	15,828	15,754,537	91,881,150	May 07 04:00 PM
LILLY ENDOWMENT, INC.	Shareholder	May 06 '26	Proposed Sale	988.87	300,000	296,661,000		May 06 04:35 PM
Zakrowski Donald A	SVP, Finance, & CAO	Feb 16 '26	Option Exercise	0.00	184	0	3,607	Feb 18 04:22 PM
Montarce Lucas	EVP & CFO	Feb 16 '26	Option Exercise	0.00	368	0	16,418	Feb 18 04:21 PM
Custer Kenneth L.	EVP & President, Card Met Hlth	Feb 16 '26	Option Exercise	0.00	207	0	10,232	Feb 18 04:21 PM
Brown Adrienne S	EVP, President LLY Imm	Feb 16 '26	Option Exercise	0.00	391	0	5,312	Feb 18 04:19 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your Finviz experience